What happened
The World Economic Forum published a strategic framework examining how AI is fundamentally transforming life sciences and medtech—not only by accelerating discovery but by reshaping how value is created, delivered, and captured. The report argues that as AI removes long-standing constraints in research, the bottleneck is shifting downstream to development, evidence generation, and real-world impact. Drawing on insights from senior industry leaders and global analysis, it outlines the strategic choices organizations must make to remain competitive in this new landscape and highlights the growing importance of public-private alignment, as regulation, reimbursement, and data governance increasingly shape which innovations can scale.
Why it matters
Life sciences executives face a strategic inflection point: AI is redefining where value is captured in the innovation cycle. This framework provides a board-level roadmap for navigating the shift from discovery-centric to deployment-centric competition, with implications for capital allocation, regulatory strategy, and partnership models.
Action needed
Executive teams should map their current R&D and commercialization bottlenecks against the framework's strategic choices by end of Q2, identifying where AI shifts value capture in their pipeline.